QbD in Pharma Development 2013

The federal agencies have adopted the concept of Quality-by-Design (QbD) in the pharma industry in order to enhance product and process quality. The key elements of QbD include the CQAs, QTPP, design space, QRM, continuous improvement and control strategy.

QbD in Pharma Development 2013 is a seminar that covers topics such as:

• FbD Implementation using Optimization Designs
• FbD and DOE using Pertinent Software Packages
• Prioritization using QRM, FMEA & Screening Designs
• Key Issues in Earmarking Design and Control Spaces
• QbD for API & Excipients
• QbD for Analytical Development
• QbD Overview & Fedral Requirements
• QbD in Product Development using FbD
• QbD/FbD Case Studies

The QbD in Pharma Development 2013 seminar includes an exhibition showcasing the latest techniques available for implementation of QbD in the pharmaceutical industry.

QbD in Pharma Development 2013 brings together scientists from academia and industry involved in Process R & D, Product Development, Manufacturing, Scale-up, Global Regulatory Affairs, Quality Assurance, Excipients, API, Technology Transfer and Pharmaceutical Analysis.